Core Viewpoint - Haitec (301022) reported significant growth in its 2025 semi-annual results, with revenue and net profit reaching historical highs, driven by increased orders and capacity release in its injection mold business [1][2]. Group 1: Financial Performance - The company achieved a revenue of 386 million yuan, representing a year-on-year increase of 24.86% [1]. - The net profit attributable to shareholders was 36.38 million yuan, up 383.49% year-on-year [1]. - The net profit excluding non-recurring items reached 33.83 million yuan, marking a substantial increase of 1451.28% [1]. Group 2: Business Development - The growth in the injection mold business is attributed to both increased orders and the release of production capacity [1]. - The company is advancing its convertible bond project for an annual production of 150,000 tons of high polymer new materials, with a pilot production base in Qingdao already established [1]. - The company is actively expanding into the humanoid robot sector, having successfully entered this market and is currently developing components for a leading domestic humanoid robot company [1]. Group 3: Research and Development - Haitec increased its R&D investment to 14.50 million yuan, a growth of 7.20% year-on-year [2]. - The company has obtained 7 patents in high polymer materials, bringing its total patent count to 105 [2]. - The focus on modified PEEK materials highlights the company's commitment to the humanoid robot market, leveraging the material's advantages such as low density and excellent mechanical properties [2].